Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study.
2019
e12507Background: T-DM1 is widely used in HER2 positive
metastatic breast cancer(MBC) patients (pts), often for many cycles until progression. However, little is known about its long term toxicity...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
3
Citations
NaN
KQI